GlassScriptPhysician profile
David M Clark
NPI 1225010754
$12,913.44
in general payments reported to CMS, 2019-2025
18 companies · $1,476 in 2025
The $1,476 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,271 · 2020: $194 · 2021: $412 · 2022: $650 · 2023: $3,794 · 2024: $3,116 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,184 · Travel and Lodging: $3,175 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,183.94 |
| Travel and Lodging | $3,174.93 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,623.71 | 2019-2025 | Watchman Flx, Farapulse, General - Therapies |
| Medtronic, INC. | $2,582.66 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Cobalt Dr Mri Surescan, Arctic Front Advance |
| Abbott Laboratories | $1,812.37 | 2019-2025 | Amplatzer Amulet, Ensite, Advisor |
| Medical Device Business Services, INC. | $1,578.33 | 2024 | Carto 3 |
| Baylis Medical Company INC | $1,144.38 | 2019 | |
| Atricure, INC. | $643.08 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cardiva Medical, INC. | $495.54 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Cardiva Vascade 6/7f Vcs |
| Biosense Webster, INC. | $490.55 | 2019-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.70 | 2020-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $101.61 | 2019-2021 | |
| Davol INC. | $55.13 | 2025 | Arista |
| Pfizer INC. | $31.64 | 2022 | |
| Angiodynamics, INC. | $18.56 | 2021 | |
| Novo Nordisk INC | $16.97 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.58 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $16.01 | 2023 | |
| Medtronic Vascular, INC. | $15.62 | 2020 | |
| Bardy Diagnostics, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.